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Abstract 
Combined central retinal artery and vein occlusion is an uncommon vascular pathology that 
can cause severe and permanent visual impairment. Optical coherence tomography angiog-
raphy (OCTA) is a newly available, noninvasive imaging technique that can potentially improve 
understanding of the structural and vascular implications and prognosis of this infrequent pa-
thology. The present report describes the principal clinical findings in a case of combined cen-
tral retinal artery and vein occlusion, as detected by the different imaging modalities available 
in a tertiary referral hospital. OCTA wide-field montage images identified an extensive area of 
nonperfusion on the macula with involvement of the entire retina at nearly 360°. We observed 
the most severe nonperfusion in the deep capillary plexus, while perfusion of the choriocapil-
laris was unaffected. Meanwhile, fluorescein angiography (FA) findings revealed a delay in per-
fusion rate with marked nonperfusion areas in the peripheral retina at 360°. We identified that 
the wide-field OCTA montage permitted visualization of a similar or wider peripheral retinal 
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area compared with FA. Therefore, OCTA is potentially useful for assessment of the global 
retinal nonperfusion status at baseline and during follow-up, with the added advantage of 
being a noninvasive technique. © 2019 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Retinal vein occlusion (RVO) is the second most frequent cause of retinal vascular disease 
after diabetic retinopathy [1]. Its most severe manifestation is ischemic central RVO (CRVO), 
which causes visual impairment and a risk of neovascularization. Combined central retinal 
artery occlusion (CRAO) and CRVO is an uncommon vascular pathology generally associated 
with systemic disease such as immunological illnesses, malignancies, and coagulopathies [2]. 
Fluorescein angiography (FA) has remained the gold standard for visualization of the vas-
cular pathologies of retinal diseases until the advent of optical coherence tomography angi-
ography (OCTA), a novel and noninvasive technique based on OCT technology. OCTA is not a 
substitute, but rather a complementary technique, to previously available imaging techniques. 
OCTA enables independent visualization of not only the superficial capillary plexus (SCP), but 
also the deep capillary plexus (DCP) and the choriocapillaris, allowing a better understanding 
of retinal vascular injuries and pathologies. 
The aim of the present report was to describe and illustrate the principal clinical findings 
in a patient diagnosed with combined CRVO and CRAO. To our knowledge, this report is the 
first to directly compare FA and wide-field OCTA montage findings in this uncommon pathol-
ogy. 
Case Report 
An 82-year-old man presented with a 2-week history of sudden painless permanent 
blurred vision in his right eye (OD), without any systemic symptoms such as headache, poly-
myalgia rheumatic, or jaw claudication that would be indicative of giant cell arteritis. The pa-
tient did not report vision loss or other alterations in his left eye (OS). He had a history of 
arterial hypertension, dyslipidemia, and atrial fibrillation treated with antihypertensive drugs 
and statins, and was a former smoker. The patient received treatment with acenocoumarol 
some months prior to the onset of symptoms, but at the time of the first visit, and by his own 
decision, the patient was not taking this treatment. He reported no surgical or medical oph-
thalmological history. 
The patient underwent a complete ophthalmic examination at baseline and at the 3- and 
6-month follow-up visits, including best-corrected visual acuity (BCVA) measurement with 
the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, intraocular pressure (IOP) 
measurement, anterior segment examination, funduscopic study, gonioscopy, OCT, and OCTA 
with a Swept Source OCT Triton (Topcon Corp., Tokyo, Japan) performing 3 × 3 and 6 × 6 mm 
captures centered on the fovea. Wide-field OCTA montages were also performed with periph-
eral 6 × 6 and 9 × 9 mm images captured at baseline and at the 3- and 6-month follow-up visits. 
Adobe Photoshop CC 2018 (Adobe Systems, San Jose, CA, USA) was used to manually create 
the montages. FA (Spectralis Heidelberg Engineering, Heidelberg, Germany) was also per-
formed at baseline and at the 6-month follow-up visit. 
At the first visit, the BCVA was hand motion in the OD and 20/32 in the OS; IOP was 14 
and 12 mm Hg, respectively. Slit lamp examination detected a bilateral nuclear cataract. 
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Funduscopic study revealed hypertensive retinopathy grade 1 and disperse drusen in the OS. 
The retina of the right eye had a congested appearance with papillary edema, and intraretinal 
and widespread flame-shaped hemorrhages in all four quadrants, prompting a diagnosis of 
CRVO. Baseline OCT line HD and macular OCTA findings of 3 × 3 and 6 × 6 mm captures cen-
tered on the fovea; initial FA findings are shown and explained in Figure 1. 
Anti-VEGF therapy was the first-line treatment for the patient. He received an initial load-
ing dose of 3-monthly intravitreal injections of aflibercept, followed by a pro re nata regimen 
over a 6-month period. 
At the 3-month funduscopic examination, resorption of the hemorrhages had improved 
visualization of the vascular structures. Fundus color photography identified more scattered 
flame-shaped hemorrhages than at baseline, without papillary edema, and extensive emboli 
on the principal temporal retinal arteries. The latter presented a funduscopic appearance of 
platelet-fibrin emboli due to their duller white-gray coloration and their stretched arrange-
ment in the arterial lumen. OCT line HD identified more evident inner-layer hyperreflectivity 
and an important atrophy of inner and outer layers, without retinal edema. Red-free filter 
photography revealed hyperreflective images corresponding to the emboli on the fundus 
color photography, confirming the final diagnosis of combined CRVO and CRAO. The absence 
of whitish coloration of nonperfused retina can be explained by the time of evolution since the 
diagnosis, until the hemorrhages disappeared, as this sign usually lasts a few weeks. The mac-
ular OCT and OCTA findings of the 3-month follow-up visit are shown and described in Figure 
2. The wide-field OCTA montage at the 3-month follow-up visit indicated extensive macular 
and peripheral nonperfusion areas (Fig. 2).  
At the 3-month follow-up visit, the BCVA was counting fingers in the OD, which remained 
unchanged at the 6-month follow-up. In the OS, an IOP of 28 mm Hg at the 3-month examina-
tion prompted treatment with a topical prostaglandin analog. The OD with CRVO and CRAO 
had normal-range IOP. At the 6-month follow-up visit, the patient had not developed rubeosis 
iridis on the OD, and gonioscopy demonstrated an open angle without signs of angle neovas-
cularization. The funduscopic examination remained similar to that described at the 3-month 
follow-up visit, without signs of retinal neovascularization. However, some slight differences 
in the location of the emboli could be observed, which supports the diagnosis of platelet-fibrin 
emboli causing CRAO. Autofluorescence photography showed hyperautofluorescent images 
corresponding to emboli observed in the fundus color photography. Macular OCT and OCTA 
findings, as well as the final FA and wide-field OCTA montages performed at the 6-month fol-
low-up visit, are shown and described in Figure 3. 
Discussion 
OCTA is a novel, noninvasive imaging method based on the flow rate of erythrocytes mov-
ing above a detection rate threshold through the blood vessel lumen. OCTA uses algorithms to 
measure the variation in reflected OCT signal amplitude between consecutive cross-sectional 
B-scans, generating high-quality angiograms of the retina and choroid [3]. SS-OCT Triton was 
used to obtain OCTA images. This instrument has an A-scan rate of 100,000 scans/s, and uses 
OCTARA© detection software, which is more sensitive in the detection of low or slow blood 
flow than other OCTA methods and is the only commercially available SS-OCTA with a 1,050-
nm light source [4].  
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In the past 4 years, OCTA has been used to identify previously unknown pathophysio- 
logical features of retinal vascular diseases such as branch RVO (BRVO) [5–7], CRVO [5, 7, 8], 
and RAO [9, 10]. 
Prior findings have suggested that the DCP is most significantly damaged by RVO [5, 11], 
necessitating independent evaluation of each plexus. OCTA provides stratigraphic vascular 
details that have not previously been described with standard FA, which may assist assess-
ments of the extent of retinal nonperfusion areas at baseline and during follow-up. Further-
more, this can provide information than can help predict responses to anti-VEGF treatment 
and vascular prognosis in vascular diseases. In addition, OCTA technology has the added ad-
vantages of being noninvasive and less time-consuming. 
Chung and Li [12] reported a case of BRVO and performed a wide-field montage before 
and after anti-VEGF treatment, which yielded a visualization area of 8 × 8 mm. This is smaller 
than the area achieved in the second and third montages in our case. 
Kaya et al. [13] reported a case of cilio-RAO combined with CRVO, comparing macular 
OCTA findings with FA images 10 months after treatment with a single intravitreal injection 
of dexamethasone. In such a chronic phase of the disease, FA showed normal filling of the cil-
ioretinal artery with correct perfusion of the retinal capillary network on the macula. Con-
versely, OCTA identified nonperfusion areas in both the SCP and DCP, demonstrating its supe-
riority over FA in evaluating the vascular status of the macula in this disease. In our study, we 
compared FA and OCTA findings not only in the chronic phase but also at baseline. This al-
lowed us to perform suitable imaging of the macula and detect the presence of wide areas of 
macular ischemia on the SCP and suspected nonperfused areas on the DCP even at the first 
visit, and to predict the vascular evolution of the disease and its response to treatment. Fur-
thermore, Kaya et al. [13] did not study the peripheral findings on OCTA, as we did.  
Wu et al. [14] presented an interesting case of combined CRVO and CRAO that occurred 9 
days following cataract surgery with retrobulbar anesthesia, reporting major OCT and OCTA 
macular findings in this rare pathology for the first time. As reported here, the authors ob-
served the absence of perfusion in both capillary layers on OCTA, with minimal involvement 
of choriocapillaris. OCT revealed inner-layer hyperreflectivity of the retina and structural al-
teration of the external layers. Unfortunately, they did not report OCT, OCTA, or FA follow-up 
findings. Moreover, they did not include peripheral OCTA montages nor did they compare 
their findings with FA, so no information regarding peripheral perfusion was provided. As de-
scribed in these prior studies, and confirmed in our report, the choriocapillaris layer appears 
to be unaffected in combined CRVO and CRAO. 
The present study evaluated a case of combined CRVO and CRAO not only with macular 
OCTA images but also with wide-field OCTA montages to compare the nonperfusion status 
with FA. 
Our patient presented poor fixation at the baseline visit. This enabled us to perform OCTA 
in the macular and papillary area, but not in the peripheral retina. However, these images pro-
vided more information regarding the posterior pole nonperfusion status in the SCP than did 
FA, due to limited visualization of retinal perfusion with FA caused by the screen effect of the 
hemorrhages and the contrast leakage. Kashani et al. [15] demonstrated that in OCTA, retinal 
perfusion can only be assessed in the retinal layers superficial to those involved with intraret-
inal hemorrhages, as the hemorrhages block the OCTA signal to some extent and cause dis-
ruption of the capillary network with no flow signal. Furthermore, intraretinal hemorrhages 
in CRVO are detected more frequently in DCP than in SCP [15]. Therefore, OCTA allows us to 
reliably visualize the SCP but not the DCP in the presence of intraretinal hemorrhages. Alt-
hough neither technique could initially provide us with information about the DCP due to 
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hemorrhages, OCTA gave us at least the same information about macular SCP as FA, with a 
higher level of capillary resolution, which is difficult to achieve using standard FA.  
At the 6-month post-treatment visit, the wide-field OCTA montage permitted visualiza-
tion of a similar or wider peripheral area than did the FA image. Although OCTA does not pro-
vide dynamic information about vascular flow, the present study suggests that it is a useful 
tool for assessment of the global nonperfusion status of the retina at baseline and during fol-
low-up. Furthermore, OCTA can be performed at every visit and in every patient.  
The main limitation of this technique is that it is time-consuming to obtain the wide-field 
OCTA montage; therefore, the development of automated montage software should be con-
sidered because it would be less time-consuming and easier to implement in clinical practice. 
To our knowledge, this is the first report to describe the main macular and peripheral 
OCTA findings of a case of combined CRVO and CRAO, in addition to complete imaging findings 
at baseline and at the 3- and 6-month follow-up visits, including global perfusion status visu-
alization with SS-OCTA wide-field montages. This report contributes to the understanding of 
the structural and vascular implications and prognosis of this uncommon disease, without the 
invasiveness of classic angiography techniques. 
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Fig. 1. Baseline fundus color photography (a) and fluorescein angiography (FA) (b). Optical coherence to-
mography angiography (OCTA) of the superficial capillary plexus (SCP) (c) and deep capillary plexus (DCP) 
(d) in the 3 × 3 mm area centered on the fovea, and of the SCP (e) and DCP (f) in the 6 × 6 mm area centered 
on the fovea. g Baseline macular OCT line HD. h OCTA montage of the posterior pole. FA could not define 
the presence of macular or peripheral ischemia due to the screen effect from hemorrhage blockage. OCTA 
revealed a severe macular nonperfusion area on the 3 × 3 and 6 × 6 mm images. Despite the retinal hem-
orrhages, OCTA provided independent information about SCP and DCP. However, DCP was mainly affected 
by intraretinal hemorrhages, thus the lower patched reflectivity shown in DCP macular images could cor-
respond to intraretinal hemorrhages rather than nonperfused areas. Baseline OCT line HD revealed in-
traretinal hemorrhages and a 1,108-μm-thick central macular edema with a 5,173-μm-length neurosenso-
rial detachment and a subtle hyperreflectivity of the inner macular layers that went unnoticed during the 
first examination. The posterior pole OCTA montage shows motion artifacts, which were caused by poor 
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Fig. 2. Three-month follow-up fundus color photography (a), macular OCT line HD (b), and en face 3 × 3 
mm superficial capillary plexus (SCP) (c) and deep capillary plexus (DCP) (d) images. OCTA images of the 
SCP (e) and DCP (f) in the 3 × 3 mm area centered on the fovea, and SCP (g) and DCP (h) in the 6 × 6 mm 
area centered on the fovea. i Wide-field OCTA montage (6 × 6 mm images). Fundus color photography 
revealed scattered flame-shaped hemorrhages without papillary edema and extensive white-gray images 
within the arterial lumen with the appearance of platelet-fibrin emboli on the principal temporal retinal 
arteries (blue arrows). OCT line HD revealed an evident inner-layer hyperreflectivity (green arrows) and 
an important atrophy of external layers, without retinal edema. OCTA images indicated the nonperfusion 
status of the macula, which was present in both the SCP and DCP. The wide-field OCTA montage revealed 
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Fig. 3. Six-month follow-up fundus color photography (a) and fluorescein angiography (FA) (b). En face  
3 × 3 mm superficial capillary plexus (SCP) (c) and deep capillary plexus (DCP) (d) images. OCTA of the 
SCP (e) and DCP (f) in the 3 × 3 mm area centered on the fovea, and SCP (h) and DCP (i) in the 6 × 6 mm 
area centered on the fovea. OCTA of the choriocapillaris in the 3 × 3 (g) and 6 × 6 (j) mm areas centered on 
the fovea. k Six-month follow-up macular OCT line HD. Wide-field OCTA montage made with 6 × 6 mm (l) 
and 9 × 9 mm (m) images. Fundus color photography revealed extensive emboli on the principal temporal 
retinal arteries (blue arrows). Compared to the 3-month follow-up fundus color photography, some differ-
ences in the location of the emboli can be observed. FA images at the end of follow-up revealed a delayed 
perfusion rate with localized thinning of the arterial vascular lumen close to the papilla and marked non-
perfusion areas in the peripheral retina at 360°, without evidence of retinal neovascularization. In such a 
chronic phase of the disease, the arterioles might be reperfused, so no stops in the vascular column could 
be observed. FA does not show any vascular leakage or staining. Macular OCTA images revealed severe 
involvement of the deep capillary plexus, with no change in perfusion of the choriocapillaris. OCT line HD 
showed an important atrophy of the external layers, without retinal edema (green arrows). The OCTA 
wide-field montage images demonstrated an extensive nonperfusion area on the macula with involvement 
of the entire retina at nearly 360°. Principal temporal arteries are entirely represented in OCTA, thus we 
assume that these arteries are reperfused. The OCTA montages allowed visualization of at least the same 
or wider nonperfusion peripheral areas compared with FA. 
 
